Prognostic value of systemic inflammation response index in successfully recanalized acute large vessel occlusion stroke patients: a retrospective study - Report - MDSpire

Prognostic value of systemic inflammation response index in successfully recanalized acute large vessel occlusion stroke patients: a retrospective study

  • By

  • Wangyu Zhang

  • Congcong Zhou

  • Xuan Xu

  • Guomei Du

  • Shuqin Liang

  • Tong Xu

  • Han Zhao

  • Jiaou Chen

  • May 28, 2026

  • 0 min

Share

Clinical Report: Prognostic Significance of Systemic Inflammation Response Index in ALVOS

Overview

This study evaluates the association between baseline Systemic Inflammation Response Index (SIRI) and 90-day functional outcomes in patients with acute large vessel occlusion stroke (ALVOS) post-recanalization. No significant association with hemorrhagic transformation was found.

Background

Acute large vessel occlusion stroke (ALVOS) is a critical condition that often leads to significant morbidity and mortality. Despite advancements in endovascular therapy (EVT), many patients experience poor functional outcomes after successful recanalization. Identifying reliable prognostic indicators, such as the Systemic Inflammation Response Index (SIRI), is essential.

Data Highlights

OutcomeGood Outcome (mRS 0-2)Poor Outcome (mRS 3-6)
SIRI Level1.26 ± 1.102.22 ± 2.42

Key Findings

  • The mean age of the study cohort was 70.9 ± 13.0 years, with 58.5% being male.
  • The mean SIRI level was significantly lower in the good outcome group compared to the poor outcome group (p < 0.001).
  • The area under the ROC curve for SIRI predicting a poor outcome was 0.63 (95% CI: 0.56–0.69, P<0.001).
  • Incorporating SIRI into the age + NIHSS model improved prognostic accuracy (AUC increase from 0.76 to 0.79, p = 0.023).
  • No significant association was found between SIRI levels and hemorrhagic transformation (OR 1.08, p = 0.29).

Clinical Implications

SIRI may serve as a biomarker for predicting functional outcomes in ALVOS patients post-EVT.

Conclusion

Higher baseline SIRI levels are associated with poorer functional outcomes at 90 days in ALVOS patients after EVT, while no link to hemorrhagic transformation was established.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Author(s)/Org, Source, Year -- Title
  6. Large-Core Ischemic Stroke Endovascular Treatment - Professional Heart Daily
  7. European Stroke Organisation and European Society for Minimally Invasive Neurological Therapy guideline
  8. Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
  9. Comprehensive Meta-Analysis of Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: Prevalence, Factors, and Clinical Outcomes
  10. Systemic Inflammatory Response Index and the Short-Term Functional Outcome of Patients with Acute Ischemic Stroke: A Meta-analysis | Neurology and Therapy | Springer Nature Link
  11. Systemic Inflammation Response Index and Systemic Immune-Inflammation Index Are Associated with Clinical Outcomes in Patients Treated with Mechanical Thrombectomy for Large Artery Occlusion - ScienceDirect
  12. Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy | New England Journal of Medicine

Original Source(s)

Related Content